Chondrodysplasia punctata and maternal warfarin use during pregnancy.
D000014:Abnormalities, Drug-Induced; D000437:Alcoholism / Q000150:complications; D002561:Cerebrovascular Disorders / Q000139:chemically induced / Q000188:drug therapy*; D002806:Chondrodysplasia Punctata / Q000139:chemically induced* / Q000000981:diagnostic imaging; D003276:Contraceptives, Oral / Q000009:adverse effects; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011859:Radiography; D012214:Rheumatic Heart Disease / Q000150:complications; D013315:Stress, Psychological; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
D003276:Contraceptives, Oral; D014859:Warfarin; D005665:Furosemide; D003975:Diazepam